603392 万泰生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.4310.8519.96556.35357.592
总资产报酬率 ROA (%)-0.3620.6997.81240.69338.323
投入资产回报率 ROIC (%)-0.4160.8219.62653.87553.908

边际利润分析
销售毛利率 (%)66.55166.19684.15489.53685.780
营业利润率 (%)-13.9274.17925.43150.03140.493
息税前利润/营业总收入 (%)-16.0120.41923.59849.36140.508
净利润/营业总收入 (%)-13.5144.85922.61943.48036.158

收益指标分析
经营活动净收益/利润总额(%)111.131-222.609117.12997.395100.950
价值变动净收益/利润总额(%)-53.255216.8678.8670.8260.484
营业外收支净额/利润总额(%)3.633-39.058-0.578-0.239-0.185

偿债能力分析
流动比率 (X)4.1374.1623.8583.4951.964
速动比率 (X)3.6153.7333.5193.2451.713
资产负债率 (%)14.34715.25918.01722.58035.247
带息债务/全部投入资本 (%)2.2672.5183.2152.6285.144
股东权益/带息债务 (%)4,262.8283,828.6242,999.3583,682.8421,798.492
股东权益/负债合计 (%)588.146547.096448.572336.767179.842
利息保障倍数 (X)10.266-0.162-13.986-89.610448.350

营运能力分析
应收账款周转天数 (天)440.949403.347226.37099.70192.256
存货周转天数 (天)612.847419.425365.800224.891218.631